EAS Paediatric FH symposium

Programme

Organised by:
Noel Peretti, Marianne Becker, Olivier Descamps, Jeanine Roeters van Lennep, Urh Grošelj, Mafalda Bourbon, Kirsten Holven, Michal Vrablik, Magdalena Daccord and Steve Humphries

10.00-10.05	Welcome – Steve Humphries (UK) and Noel Peretti (France)
10.05-11.20	Rare dyslipidemias in children: Clinical presentation and early diagnosis  Chairs: Noel Peretti (France) and Magdalena Daccord (FH Europe)
10.05-10.20	Familial Chylomicron Syndrome (FCS) – Sybile Charriere (France)
10.20-10.35	Living with Familial Chylomicronaemia Syndrome – the patient experience – Jill Prawer (FH Europe Foundation)
10.35-10.50	Lysosome Acid Lipase Deficiency (LAL-D)  – Stella Reichmannova (Czech Republic)
10.50-11.05	Sitosterolaemia – Diagnosis, Genetics and Management  – Emil Asprusten (Norway)
11.05-11.25	2x Clinical Scenarios – Led by Uma Ramaswami (UK)
11.25-11.50	Coffee break
11.50-13.00	Is it time to lower targets for initiation and on treatment LDL-C? Chairs: Kirsten Holven (Norway) and Marianne Becker (Luxembourg)
11.50-12.05	The update of the EAS Paediatric FH Guidelines  – Albert Wiegman (The Netherlands)
12.05-12.20	Treatment goals in FH – time to consider LDL-C burden – Martin Bogsrud (Norway)
12.20-12.35	Do we need different LDL-C thresholds/targets in different countries? – Kanika Dharmayat (UK)
12.35-12.50	The IAS initiative on Neonatal screening for FH – Raul Santos (Brazil)
12.50-12.55	Compassionate Use of Evinacumab for the Treatment of Homozygous Familial Hypercholesterolaemia (HoFH) in Children Under 5 Years of age: Clinical Experience – Brian McCrindle (Canada)
13.00-14.00	Lunch
14.00-15.50	How to maximise compliance and adherence to treatment in adolescents with FH Universal Screening in childhood Chairs: Mafalda Bourbon (Portugal)and Jeanine Roeters van Lennep (The Netherlands)
14.00-14.20	What psychological factors influence adherence to treatment in childhood and adolescence? – Fiona Kinnear (UK)
14.20-14.35	Maximising adherence: The Australian experience – Gerald Watts (Australia)
14.35-14.50	Predicting non-adherence in patients with FH – Annette Galema-Boers (Netherlands)
14.50-15.10	What do patients find that encourages or discourages adherence to medication and lifestyle advice – Elsie Evans (UK) & Danique van den Bogert (The Netherlands)
15.10-15.25	What can we learn from the experience with Type 1 Diabetes – Carine de Beaufort (Luxembourg)
15.25 -15.50	Round table discussion with all speakers
15.50-16.00	Voting for next year’s topics and Wrap up – Steve Humphries (UK)
16.00-17.00	Networking drinks

*The symposium is free of charge for all delegates. Please note that a no-show fee of €100 will be charged if you cancel your participation later than Friday 12 May or do not show up at the symposium.

Thank you to our sponsors